Asuragen

Presence

Asuragen is owned by Bio-Techne.


Bio-Techne is one of the...

Bio-Techne is a company listed under the stock ticker TECH (US).

They are in:

Acquisition, funding and merger involving Bio-Techne.

Executives

View the org chart displaying its 8 main executives

Most searched biographies at Asuragen
Popular executive movements at Bio-Techne
  • Matthew Mcmanus will join the company as President, Diagnostics and Genomics Segment on Feb. 1, 2024  (posted on January 7 2024).
  • Kim Kelderman who is President, Diagnostics and Genomics, will be promoted to Director, President and Chief Executive Officer on Feb. 1, 2024  (posted on October 19 2023).

Create your alert
to follow the executive moves at Asuragen.

Biotechnology

Bio-Techne has 2,277 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry >

News

Press releases by Asuragen
Social media about Asuragen

Get in Touch

Contact by email its executives including Matt Winkler Premium

Call Asuragen at +1 512...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Executive Data Sets
Executives
Companies
The Official Board